Literature DB >> 25767131

Association of a lifestyle index with MRI-determined liver fat content in a general population study.

Manja Koch1, Jan Borggrefe2, Sabrina Schlesinger1, Janett Barbaresko3, Godo Groth4, Gunnar Jacobs5, Wolfgang Lieb6, Matthias Laudes7, Manfred J Müller8, Anja Bosy-Westphal9, Martin Heller4, Ute Nöthlings3.   

Abstract

BACKGROUND: In prior studies, lifestyle indices were associated with numerous disease end points, but the association with fatty liver disease (FLD), a key correlate of cardiometabolic risk, is unknown. The aim was to investigate associations between a lifestyle index with liver fat content.
METHODS: Liver fat was quantified by MRI as liver signal intensity (LSI) in 354 individuals selected from a population-based cohort from Germany. Exposure to favourable lifestyle factors was quantified using an additive score with each factor modelled as a dichotomous trait. Favourable lifestyle factors were defined as waist circumference below 102 (men) or 88 cm (women), physical activity ≥3.5 h/week, never-smoking and a favourable dietary pattern, which was derived to explain liver fat variation. In a cross-sectional study, multivariable adjusted linear and logistic regression was applied to investigate the association between the lifestyle index (range 0-4, exposure) and LSI (modelled as a continuous trait or dichotomised as a FLD indicator variable, respectively).
RESULTS: Individuals with four favourable lifestyle factors (n=9%) had lower LSI values (ß -0.40; 95% CI -0.61 to -0.19) and a lower OR (0.09; 95% CI 0.03 to 0.30) for FLD compared with individuals with zero favourable lifestyle factors (n=10%).
CONCLUSIONS: A healthy lifestyle pattern was associated with less liver fat. Prospective studies are warranted. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Epidemiology of chronic non communicable diseases; LIFESTYLE; NUTRITION; OBESITY; PHYSICAL ACTIVITY

Mesh:

Year:  2015        PMID: 25767131     DOI: 10.1136/jech-2014-204989

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  5 in total

Review 1.  Nonalcoholic fatty liver disease: lifestyle and quality of life.

Authors:  Ilias Vachliotis; Antonis Goulas; Paraskevi Papaioannidou; Stergios A Polyzos
Journal:  Hormones (Athens)       Date:  2021-12-01       Impact factor: 2.885

2.  Association between smoking and non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Authors:  Arash Akhavan Rezayat; Malihe Dadgar Moghadam; Mohammad Ghasemi Nour; Matin Shirazinia; Hamidreza Ghodsi; Mohammad Reza Rouhbakhsh Zahmatkesh; Mitra Tavakolizadeh Noghabi; Benyamin Hoseini; Kambiz Akhavan Rezayat
Journal:  SAGE Open Med       Date:  2018-01-24

3.  The association between adherence to the Mediterranean diet and hepatic steatosis: cross-sectional analysis of two independent studies, the UK Fenland Study and the Swiss CoLaus Study.

Authors:  Saman Khalatbari-Soltani; Fumiaki Imamura; Soren Brage; Emanuella De Lucia Rolfe; Simon J Griffin; Nicholas J Wareham; Pedro Marques-Vidal; Nita G Forouhi
Journal:  BMC Med       Date:  2019-01-24       Impact factor: 8.775

4.  Smoking results in accumulation of ectopic fat in the liver.

Authors:  Ayako Kato; Yuanying Li; Atsuhiko Ota; Hisao Naito; Hiroya Yamada; Takashi Nihashi; Yo Hotta; Chifa Chiang; Yoshihisa Hirakawa; Atsuko Aoyama; Koji Tamakoshi; Hiroshi Yatsuya
Journal:  Diabetes Metab Syndr Obes       Date:  2019-07-09       Impact factor: 3.168

5.  Metabolic Inflexibility Is an Early Marker of Bed-Rest-Induced Glucose Intolerance Even When Fat Mass Is Stable.

Authors:  Floriane Rudwill; Donal O'Gorman; Etienne Lefai; Isabelle Chery; Alexandre Zahariev; Sylvie Normand; Allan F Pagano; Angèle Chopard; Anthony Damiot; Claire Laurens; Leanne Hodson; Emmanuelle Canet-Soulas; Martina Heer; Petra Frings Meuthen; Judith Buehlmeier; Natalie Baecker; Laure Meiller; Guillemette Gauquelin-Koch; Stéphane Blanc; Chantal Simon; Audrey Bergouignan
Journal:  J Clin Endocrinol Metab       Date:  2018-05-01       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.